Kasper Lind Hoffmann

Kasper Lind Hoffmann is a Senior CMC Specialist in Analytical at Genmab since November 2023, previously serving as CMC Analytical Development Leader at Galapagos from November 2019 to October 2023. With extensive experience at Ferring Pharmaceuticals as a Senior Research Scientist and Analytical Development Lead, Hoffmann has specialized in analytical development for peptides and small molecules. Additional roles include Clinical Pharmacist at Region Hovedstadens Apotek and Research Scientist in Analytical Development at Novo Nordisk A/S, contributing to oral formulation and early-phase analytics. Hoffmann completed a Master’s degree in Pharmaceutical Sciences from The Danish University of Pharmaceutical Sciences in 2006, alongside a brief tenure as a PhD student.